These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9165638)
21. Longitudinal courses of thought disorder in schizophrenia and schizoaffective disorder. Marengo JT; Harrow M Schizophr Bull; 1997; 23(2):273-85. PubMed ID: 9165637 [TBL] [Abstract][Full Text] [Related]
22. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. Goldberg JF; Harrow M J Affect Disord; 2004 Aug; 81(2):123-31. PubMed ID: 15306137 [TBL] [Abstract][Full Text] [Related]
23. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders. Quraishi S; David A Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442 [TBL] [Abstract][Full Text] [Related]
24. [The 20-Year longitudinal trajectories of social functioning in individuals with psychotic disorders]. Oorschot M; Fett AKJ; Velthorst E Ned Tijdschr Geneeskd; 2017; 161():D1645. PubMed ID: 29145902 [TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of patients with schizophrenia: a review. Jobe TH; Harrow M Can J Psychiatry; 2005 Dec; 50(14):892-900. PubMed ID: 16494258 [TBL] [Abstract][Full Text] [Related]
27. [Early detection of psychotic disorders]. Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006 [TBL] [Abstract][Full Text] [Related]
28. The relationship of premorbid functioning to illness course in schizophrenia and psychotic mood disorders during two years following first hospitalization. Haim R; Rabinowitz J; Bromet E J Nerv Ment Dis; 2006 Oct; 194(10):791-5. PubMed ID: 17041293 [TBL] [Abstract][Full Text] [Related]
29. Social disability at admission for a first psychosis does not predict clinical outcome at 5-year follow-up. Velthorst E; Nieman DH; Meijer C; Linszen D; de Haan L J Nerv Ment Dis; 2011 Jul; 199(7):510-2. PubMed ID: 21716066 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders. Sikich L J Clin Psychiatry; 2008; 69 Suppl 4():21-5. PubMed ID: 18533765 [TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning. Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184 [TBL] [Abstract][Full Text] [Related]
32. Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Morgan VA; Castle DJ; Jablensky AV Aust N Z J Psychiatry; 2008 Jan; 42(1):74-82. PubMed ID: 18058447 [TBL] [Abstract][Full Text] [Related]
33. Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia. Chiliza B; Asmal L; Kilian S; Phahladira L; Emsley R Hum Psychopharmacol; 2015 May; 30(3):173-82. PubMed ID: 25758549 [TBL] [Abstract][Full Text] [Related]
34. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey. Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824 [TBL] [Abstract][Full Text] [Related]
35. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723 [TBL] [Abstract][Full Text] [Related]
36. Neurocognitive performance, psychopathology and social functioning in individuals at high risk for schizophrenia or psychotic bipolar disorder. Gkintoni E; Pallis EG; Bitsios P; Giakoumaki SG J Affect Disord; 2017 Jan; 208():512-520. PubMed ID: 27810272 [TBL] [Abstract][Full Text] [Related]
38. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis. Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310 [TBL] [Abstract][Full Text] [Related]
39. Use of community support services by middle-aged and older patients with psychotic disorders. Shaw WS; Patterson TL; Semple SJ; Halpain MC; Koch WL; Harris MJ; Grant I; Jeste DV Psychiatr Serv; 2000 Apr; 51(4):506-12. PubMed ID: 10737827 [TBL] [Abstract][Full Text] [Related]
40. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine. Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]